Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 71023 

Controlled substance Drug 

code Schedule 

Fentanyl ...................................... 9801 II 

The company plans to manufacture 

the above controlled substances as bulk 

active pharmaceutical ingredients for 

use in product development and for 

distribution to its customers. In 

reference to drug codes 7360 

(Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–22624 Filed 10–12–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1268] 

Bulk Manufacturer of Controlled 

Substances Application: Cerilliant 

Corporation 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cerilliant Corporation, has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before December 12, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 12, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on July 12, 2023, Cerilliant 

Corporation, 811 Paloma Drive, Suite A, 

Round Rock, Texas 78665–2402, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3-FMC) .................................................................................................................................... 1233 I 

Cathinone .............................................................................................................................................................................. 1235 I 

Para-Methoxymethamphetamine (PMMA), 1-(4-1245 I N methoxyphenyl)-N-methylpropan-2-amine ................................. 1245 I 

Methcathinone ....................................................................................................................................................................... 1237 I 

4-Fluoro-N-methylcathinone (4-FMC) .................................................................................................................................... 1238 I 

Pentedrone (a-methylaminovalerophenone) ......................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) .......................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4-MEC) ...................................................................................................................................... 1249 I 

Naphyrone ............................................................................................................................................................................. 1258 I 

N-Ethylamphetamine ............................................................................................................................................................. 1475 I 

N,N-Dimethylamphetamine .................................................................................................................................................... 1480 I 

Fenethylline ........................................................................................................................................................................... 1503 I 

Aminorex ................................................................................................................................................................................ 1585 I 

4-Methylaminorex (cis isomer) .............................................................................................................................................. 1590 I 

4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4- 

methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).

1595 I 

Gamma Hydroxybutyric Acid ................................................................................................................................................. 2010 I 

Methaqualone ........................................................................................................................................................................ 2565 I 

Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ...................................... 2780 I 

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ................................. 2785 I 

Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo [f][1,2,4]triazolo[4,3-a][1,4]diazepine ....................................... 2786 I 

Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ................................ 2788 I 

Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ...................... 2789 I 

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ......................................................................................................... 6250 I 

SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ....................................................... 7008 I 

ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................... 7010 I 

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ....................... 7011 I 

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................ 7012 I 

FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ..................................................... 7014 I 

JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ............................................................................................................................. 7019 I 

MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............................. 7020 I 

FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ... 7021 I 

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................ 7023 I 

THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ....................................................................... 7024 I 

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ............................... 7025 I 

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ...................... 7031 I 

MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............... 7032 I 

5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..................................................... 7033 I 

5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .............. 7034 I 

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................ 7035 I 

5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ................................. 7036 I 

5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ...................................... 7041 I 


lotter on DSK11XQN23PROD with NOTICES1
71024 Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 

Controlled substance Drug code Schedule 

4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3- 

dimethylbutanoate).

7043 I 

MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) 7042 I 

MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ............... 7044 I 

FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3- 

carboximide).

7047 I 

APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) .................................................................. 7048 I 

5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .......................................... 7049 I 

JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ......................................................................................................... 7081 I 

5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ............................ 7083 I 

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ....................... 7085 I 

4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4- 

cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).

7089 I 

SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ........................................................................... 7104 I 

JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................... 7118 I 

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................................ 7122 I 

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ........................................................................ 7144 I 

JWH-073 (1-Butyl-3-(1-naphthoyl)indole) .............................................................................................................................. 7173 I 

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................. 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................................. 7201 I 

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ............................................................................................................ 7203 I 

NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ................................................................ 7221 I 

PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ........................................................................................................ 7222 I 

5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................................... 7225 I 

4-MEAP (4-Methyl-alpha-ethylaminopentiophenone) ............................................................................................................ 7245 I 

N-Ethylhexedrone .................................................................................................................................................................. 7246 I 

Alpha-ethyltryptamine ............................................................................................................................................................ 7249 I 

2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) ............................................................................. 7286 I 

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ....................................................................... 7297 I 

CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................. 7298 I 

Lysergic acid diethylamide .................................................................................................................................................... 7315 I 

2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ....................................................................................................... 7348 I 

Marihuana .............................................................................................................................................................................. 7360 I 

Tetrahydrocannabinols .......................................................................................................................................................... 7370 I 

Parahexyl ............................................................................................................................................................................... 7374 I 

Mescaline ............................................................................................................................................................................... 7381 I 

2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) ................................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine .............................................................................................................................................. 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ................................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................ 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ................................................................................................................................... 7395 I 

2,5-Dimethoxyamphetamine .................................................................................................................................................. 7396 I 

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ............................................................................................................ 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ...................................................................................................................................... 7399 I 

3,4-Methylenedioxyamphetamine .......................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine ........................................................................................................................ 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine ........................................................................................................................ 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................. 7404 I 

3,4-Methylenedioxymethamphetamine .................................................................................................................................. 7405 I 

4-Methoxyamphetamine ........................................................................................................................................................ 7411 I 

5-Methoxy-N-N-dimethyltryptamine ....................................................................................................................................... 7431 I 

Alpha-methyltryptamine ......................................................................................................................................................... 7432 I 

Bufotenine .............................................................................................................................................................................. 7433 I 

Diethyltryptamine ................................................................................................................................................................... 7434 I 

Dimethyltryptamine ................................................................................................................................................................ 7435 I 

Psilocybin ............................................................................................................................................................................... 7437 I 

Psilocyn ................................................................................................................................................................................. 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ................................................................................................................................... 7439 I 

4′-Chloro-alpha-pyrrolidinovalerophenone ............................................................................................................................. 7443 I 

MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ................................................................................................................. 7446 I 

N-Ethyl-1-phenylcyclohexylamine .......................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .......................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ..................................................................................................................................... 7470 I 

N-Benzylpiperazine ................................................................................................................................................................ 7493 I 

4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ........................................................................................................... 7498 I 

2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ........................................................................................................ 7508 I 

2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ............................................................................................................ 7509 I 

2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) ......................................................................................................................... 7517 I 

2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ................................................................................................................ 7518 I 

2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) .......................................................................................................... 7519 I 

2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ........................................................................................................... 7521 I 

2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .................................................................................................... 7524 I 

2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ........................................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................. 7535 I 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 71025 

Controlled substance Drug code Schedule 

25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................... 7536 I 

25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................... 7537 I 

25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................ 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ............................................................................................................ 7540 I 

Butylone ................................................................................................................................................................................. 7541 I 

Pentylone ............................................................................................................................................................................... 7542 I 

N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ........................................................... 7543 I 

a-PHP, alpha-Pyrrolidinohexanophenone ............................................................................................................................. 7544 I 

Slpha-pyrrolidinopentiophenone (a-PVP) .............................................................................................................................. 7545 I 

Alpha-pyrrolidinobutiophenone (a-PBP) ................................................................................................................................ 7546 I 

Ethylone ................................................................................................................................................................................. 7547 I 

PV8, alpha-Pyrrolidinoheptaphenone .................................................................................................................................... 7548 I 

Eutylone ................................................................................................................................................................................. 7549 I 

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .......................................................................................................... 7694 I 

Acetyldihydrocodeine ............................................................................................................................................................. 9051 I 

Benzylmorphine ..................................................................................................................................................................... 9052 I 

Codeine-N-oxide .................................................................................................................................................................... 9053 I 

Desomorphine ....................................................................................................................................................................... 9055 I 

Codeine methylbromide ......................................................................................................................................................... 9070 I 

Brorphine ............................................................................................................................................................................... 9098 I 

Dihydromorphine ................................................................................................................................................................... 9145 I 

Heroin .................................................................................................................................................................................... 9200 I 

Hydromorphinol ..................................................................................................................................................................... 9301 I 

Methyldesorphine .................................................................................................................................................................. 9302 I 

Methyldihydromorphine ......................................................................................................................................................... 9304 I 

Morphine methylbromide ....................................................................................................................................................... 9305 I 

Morphine methylsulfonate ..................................................................................................................................................... 9306 I 

Morphine-N-oxide .................................................................................................................................................................. 9307 I 

Normorphine .......................................................................................................................................................................... 9313 I 

Pholcodine ............................................................................................................................................................................. 9314 I 

U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..................................................................... 9547 I 

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ........................................................................ 9551 I 

MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ......................................................................................................... 9560 I 

Acetylmethadol ...................................................................................................................................................................... 9601 I 

Allylprodine ............................................................................................................................................................................ 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ............................................................................................................ 9603 I 

Alphameprodine ..................................................................................................................................................................... 9604 I 

Alphamethadol ....................................................................................................................................................................... 9605 I 

Betacetylmethadol ................................................................................................................................................................. 9607 I 

Betameprodine ...................................................................................................................................................................... 9608 I 

Betamethadol ......................................................................................................................................................................... 9609 I 

Betaprodine ........................................................................................................................................................................... 9611 I 

Isotonitazene ......................................................................................................................................................................... 9614 I 

Dipipanone ............................................................................................................................................................................. 9622 I 

Etonitazene ............................................................................................................................................................................ 9624 I 

Hydroxypethidine ................................................................................................................................................................... 9627 I 

Noracymethadol ..................................................................................................................................................................... 9633 I 

Norlevorphanol ...................................................................................................................................................................... 9634 I 

Normethadone ....................................................................................................................................................................... 9635 I 

Trimeperidine ......................................................................................................................................................................... 9646 I 

Phenomorphan ...................................................................................................................................................................... 9647 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................ 9661 I 

Tilidine ................................................................................................................................................................................... 9750 I 

xybenzyl)-5-nitro1Hbenzimidazol-1-yl)-N,N-diethylethan-1-amine) ....................................................................................... 9751 I 

-(2-(4-fluorobenzyl)-5-nitro1H-benzimidazol-1-yl)ethan-1-amine) ......................................................................................... 9756 I 

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine) ........................................ 9757 I 

N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1Hbenzimidazole) ........... 9758 I 

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) ....................................... 9759 I 

Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) ............................................ 9764 I 

Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1Hbenzimidazol-1-yl)-N,N-diethylethan-1-amine) .................................... 9765 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ....................................................................................... 9811 I 

Para-Fluorofentanyl ............................................................................................................................................................... 9812 I 

3-Methylfentanyl .................................................................................................................................................................... 9813 I 

Alpha-methylfentanyl ............................................................................................................................................................. 9814 I 

Acetyl-alpha-methylfentanyl ................................................................................................................................................... 9815 I 

N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................................. 9816 I 

Para-Methylfentanyl ............................................................................................................................................................... 9817 I 

4′-Methyl Acetyl Fentanyl ...................................................................................................................................................... 9819 I 

Ortho-Methyl Methoxyacetyl Fentanyl ................................................................................................................................... 9820 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ..................................................................................... 9821 I 

Butyryl Fentanyl ..................................................................................................................................................................... 9822 I 

Para-fluorobutyryl fentanyl ..................................................................................................................................................... 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ............................................... 9824 I 

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ............................................................................................... 9825 I 


lotter on DSK11XQN23PROD with NOTICES1
71026 Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 

Controlled substance Drug code Schedule 

Para-chloroisobutyryl fentanyl ............................................................................................................................................... 9826 I 

Isobutyryl fentanyl .................................................................................................................................................................. 9827 I 

Beta-hydroxyfentanyl ............................................................................................................................................................. 9830 I 

Beta-hydroxy-3-methylfentanyl .............................................................................................................................................. 9831 I 

Alpha-methylthiofentanyl ....................................................................................................................................................... 9832 I 

3-Methylthiofentanyl ............................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ................................................................... 9834 I 

Thiofentanyl ........................................................................................................................................................................... 9835 I 

Beta-hydroxythiofentanyl ....................................................................................................................................................... 9836 I 

Para-methoxybutyryl fentanyl ................................................................................................................................................ 9837 I 

Ocfentanil ............................................................................................................................................................................... 9838 I 

Thiofuranyl Fentanyl .............................................................................................................................................................. 9839 I 

Valeryl fentanyl ...................................................................................................................................................................... 9840 I 

Phenyl Fentanyl ..................................................................................................................................................................... 9841 I 

Beta′-Phenyl Fentanyl ........................................................................................................................................................... 9842 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ................................................................................ 9843 I 

Crotonyl Fentanyl .................................................................................................................................................................. 9844 I 

Cyclopropyl Fentanyl ............................................................................................................................................................. 9845 I 

Ortho-Fluorobutyryl Fenanyl .................................................................................................................................................. 9846 I 

Cyclopentyl fentanyl .............................................................................................................................................................. 9847 I 

Ortho-Methyl Acetylfentanyl .................................................................................................................................................. 9848 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ........................................................................................... 9850 I 

Fentanyl Carbamate .............................................................................................................................................................. 9851 I 

Ortho-Fluoroacryl Fentanyl .................................................................................................................................................... 9852 I 

Ortho-Fluoroisobutyryl Fentanyl ............................................................................................................................................ 9853 I 

Para-Fluoro Furanyl Fentanyl ................................................................................................................................................ 9854 I 

2′-Fluoro Ortho-Fluorofentanyl .............................................................................................................................................. 9855 I 

Beta-Methyl Fentanyl ............................................................................................................................................................. 9856 I 

8Amphetamine ....................................................................................................................................................................... 1100 II 

Methamphetamine ................................................................................................................................................................. 1105 II 

Lisdexamfetamine .................................................................................................................................................................. 1205 II 

Phenmetrazine ....................................................................................................................................................................... 1631 II 

Methylphenidate .................................................................................................................................................................... 1724 II 

Amobarbital ............................................................................................................................................................................ 2125 II 

Pentobarbital .......................................................................................................................................................................... 2270 II 

Secobarbital ........................................................................................................................................................................... 2315 II 

Glutethimide ........................................................................................................................................................................... 2550 II 

Nabilone ................................................................................................................................................................................. 7379 II 

1-Phenylcyclohexylamine ...................................................................................................................................................... 7460 II 

Phencyclidine ......................................................................................................................................................................... 7471 II 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ........................................................................................................................... 8333 II 

Norfentanyl ............................................................................................................................................................................ 8366 II 

Phenylacetone ....................................................................................................................................................................... 8501 II 

1-Piperidinocyclohexanecarbonitrile ...................................................................................................................................... 8603 II 

Alphaprodine .......................................................................................................................................................................... 9010 II 

Cocaine .................................................................................................................................................................................. 9041 II 

Codeine ................................................................................................................................................................................. 9050 II 

Dihydrocodeine ...................................................................................................................................................................... 9120 II 

Oxycodone ............................................................................................................................................................................. 9143 II 

Hydromorphone ..................................................................................................................................................................... 9150 II 

Diphenoxylate ........................................................................................................................................................................ 9170 II 

Ecgonine ................................................................................................................................................................................ 9180 II 

Ethylmorphine ........................................................................................................................................................................ 9190 II 

Hydrocodone ......................................................................................................................................................................... 9193 II 

Levomethorphan .................................................................................................................................................................... 9210 II 

Levorphanol ........................................................................................................................................................................... 9220 II 

Isomethadone ........................................................................................................................................................................ 9226 II 

Meperidine ............................................................................................................................................................................. 9230 II 

Meperidine intermediate-A .................................................................................................................................................... 9232 II 

Meperidine intermediate-B .................................................................................................................................................... 9233 II 

Meperidine intermediate-C .................................................................................................................................................... 9234 II 

Metazocine ............................................................................................................................................................................ 9240 II 

Methadone ............................................................................................................................................................................. 9250 II 

Methadone intermediate ........................................................................................................................................................ 9254 II 

Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................... 9273 II 

Morphine ................................................................................................................................................................................ 9300 II 

Thebaine ................................................................................................................................................................................ 9333 II 

Levo-alphacetylmethadol ....................................................................................................................................................... 9648 II 

Oxymorphone ........................................................................................................................................................................ 9652 II 

Noroxymorphone ................................................................................................................................................................... 9668 II 

Thiafentanil ............................................................................................................................................................................ 9729 II 

Racemethorphan ................................................................................................................................................................... 9732 II 

Alfentanil ................................................................................................................................................................................ 9737 II 

Remifentanil ........................................................................................................................................................................... 9739 II 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 71027 

Controlled substance Drug code Schedule 

Sufentanil ............................................................................................................................................................................... 9740 II 

Carfentanil ............................................................................................................................................................................. 9743 II 

Tapentadol ............................................................................................................................................................................. 9780 II 

Fentanyl ................................................................................................................................................................................. 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates and analytical reference 

standards for sale to its customers. In 

reference to drug codes 7360 

(Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–22626 Filed 10–12–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF LABOR 

[OMB Control No. 1225–0077] 

Proposed Extension of Information 

Collection; Nondiscrimination 

Compliance Information Reporting 

AGENCY: Civil Rights Center, Labor. 

ACTION: Request for public comments. 

SUMMARY: The Department of Labor, as 

part of its continuing effort to reduce 

paperwork and respondent burden, 

conducts a pre-clearance request for 

comment to provide the general public 

and Federal agencies with an 

opportunity to comment on proposed 

collections of information in accordance 

with the Paperwork Reduction Act of 

1995. This request helps to ensure that: 

requested data can be provided in the 

desired format; reporting burden (time 

and financial resources) is minimized; 

collection instruments are clearly 

understood; and the impact of collection 

requirements on respondents can be 

properly assessed. Currently, the Civil 

Rights Center (CRC) is soliciting 

comments on the information collection 

for Nondiscrimination Compliance 

Information Reporting 

DATES: All comments must be received 

on or before December 12, 2023. 

ADDRESSES: You may submit comment 

as follows. Please note that late, 

untimely filed comments will not be 

considered. 

Electronic Submissions: Submit 

electronic comments in the following 

way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Comments 

submitted electronically, including 

attachments, to https://

www.regulations.gov will be posted to 

the docket, with no changes. Because 

your comment will be made public, you 

are responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as your or anyone else’s Social 

Security number or confidential 

business information. 

• If your comment includes 

confidential information that you do not 

wish to be made available to the public, 

submit the comment as a written/paper 

submission. 

Written/Paper Submissions: Submit 

written/paper submissions in the 

following way: 

• Mail Delivery: Mail or visit DOL– 

CRC, Civil Rights Center, U.S. 

Department of Labor, 200 Constitution 

Avenue NW, Suite N4123, Washington, 

DC 20210. 

• CRC will post your comment as 

well as any attachments, except for 

information submitted and marked as 

confidential, in the docket at https://

www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Naomi Barry-Perez, Director, Civil 

Rights Center, U.S. Department of Labor 

at barry-perez.naomi@dol.gov (email); 

(202) 693–6500 (voice); or (202) 693– 

6505 (facsimile); or please dial 7–1–1 to 

access telecommunications relay 

services. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Civil Rights Center (CRC), located 

within the Department of Labor’s (DOL 

or the Department) Office of the 

Assistant Secretary for Administration 

and Management, is responsible for the 

enforcement of Section 188 of the 

Workforce Innovation and Opportunity 

Act (WIOA), which contains the 

Statute’s nondiscrimination and equal 

opportunity provisions, and its 

implementing regulations at 29 CFR part 

38. 

In addition to WIOA, entities 

receiving any financial assistance from 

DOL are subject to four intersecting civil 

rights laws over which CRC has 

enforcement authority: 

• Section 504 of the Rehabilitation 

Act of 1973, as amended, and DOL’s 

implementing regulations at 29 CFR part 

32; 

• The Age Discrimination Act of 

1972, as amended, and DOL’s 

implementing regulations at 29 CFR part 

35; 

• Title IX of the Education 

Amendments of 1972, as amended, and 

DOL’s implementing regulations at 29 

CFR part 36; and, 

• Title VI of the Civil Rights Act of 

1964, as amended, and DOL’s 

implementing regulations at 29 CFR part 

31. 

The paperwork burdens imposed by 

29 CFR parts 38 and the respective 

intersecting civil rights laws, as well as 

other Federal statutory provisions and 

regulations, are applicable to entities 

subject to the laws enforced by CRC. 

II. Desired Focus of Comments 

CRC is soliciting comments 

concerning the proposed information 

collection related to the 

Nondiscrimination Compliance 

Information Reporting. CRC is 

particularly interested in comments 

that: 

• Evaluate whether the collection of 

information is necessary for the proper 

performance of the functions of the 

Agency, including whether the 

information has practical utility; 

• Evaluate the accuracy of CRC’s 

estimate of the burden related to the 

information collection, including the 

validity of the methodology and 

assumptions used in the estimate; 

• Suggest methods to enhance the 

quality, utility, and clarity of the 

information to be collected; and 

• Minimize the burden of the 

information collection on those who are 

to respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of responses. 

Background documents related to this 

information collection request are 

available at https://regulations.gov and 

at DOL–CRC located at Civil Rights 

Center, U.S. Department of Labor, 200 

Constitution Avenue NW, Suite N4123, 

Washington, DC 20210. Questions about 

the information collection requirements 

may be directed to the person listed in 

the FOR FURTHER INFORMATION section of 

this notice. 


lotter on DSK11XQN23PROD with NOTICES1